GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Oscillate PLC (AQSE:MUSH) » Definitions » Capex-to-Revenue

Oscillate (AQSE:MUSH) Capex-to-Revenue : 0.00 (As of May. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Oscillate Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Oscillate's Capital Expenditure for the six months ended in May. 2024 was £0.00 Mil. Its Revenue for the six months ended in May. 2024 was £-0.23 Mil.

GuruFocus do not calculate Capex-to-Revenue if the revenue is negative.


Oscillate Capex-to-Revenue Historical Data

The historical data trend for Oscillate's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oscillate Capex-to-Revenue Chart

Oscillate Annual Data
Trend Nov18 Nov19 Nov21 Nov22 Nov23
Capex-to-Revenue
- - - - -

Oscillate Semi-Annual Data
May18 Nov18 May19 Nov19 May20 May21 Nov21 May22 Nov22 May23 Nov23 May24
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Oscillate's Capex-to-Revenue

For the Asset Management subindustry, Oscillate's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oscillate's Capex-to-Revenue Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, Oscillate's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Oscillate's Capex-to-Revenue falls into.



Oscillate Capex-to-Revenue Calculation

Oscillate's Capex-to-Revenue for the fiscal year that ended in Nov. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (0) / -0.104
=N/A

Oscillate's Capex-to-Revenue for the quarter that ended in May. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (0) / -0.228
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Oscillate  (AQSE:MUSH) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Oscillate Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Oscillate's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Oscillate Business Description

Traded in Other Exchanges
N/A
Address
60 Gracechurch Street, 6th Floor, London, GBR, EC3V 0HR
Oscillate PLC is an investment company whose objective is to deliver significant capital growth for shareholders through the identification and acquisition of investments in both quoted and unquoted early stage companies operating in the medicinal cannabis, medicinal psychedelics, and more generalist industry sectors.

Oscillate Headlines

No Headlines